17-31232934-T-G

Variant summary

Our verdict is Uncertain significance.
+2 Uncertain · Warm
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 2 classification points (ACGS-UK Somatic Oncogenicity v2025). O3_Moderate

The NM_001042492.3(NF1):c.3496+53T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The gene NF1 is a tumor suppressor gene (CancerMine: 101 TSG, 30 oncogene, 95 driver citations). The gene NF1 is a known oncogene (CancerMine: 101 TSG, 30 oncogene, 95 driver citations). The gene NF1 is a cancer driver gene (CancerMine: 101 TSG, 30 oncogene, 95 driver citations). The variant allele was found at a cumulative frequency of 0.000000684 (AC=1) in the gnomAD database across 1,461,378 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.0000009. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 6.8e-7 ( 0 hom. )

Consequence

NF1
NM_001042492.3 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.131

Publications

0 publications found
Variant links:
Genes affected
NF1 (HGNC:7765): (neurofibromin 1) This gene product appears to function as a negative regulator of the ras signal transduction pathway. Mutations in this gene have been linked to neurofibromatosis type 1, juvenile myelomonocytic leukemia and Watson syndrome. The mRNA for this gene is subject to RNA editing (CGA>UGA->Arg1306Term) resulting in premature translation termination. Alternatively spliced transcript variants encoding different isoforms have also been described for this gene. [provided by RefSeq, Jul 2008]
NF1 Gene-Disease associations (from GenCC):
  • neurofibromatosis type 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, ClinGen, G2P, Genomics England PanelApp
  • neurofibromatosis-Noonan syndrome
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
  • Moyamoya disease
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • hereditary pheochromocytoma-paraganglioma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial ovarian cancer
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001042492.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Uncertain_significance. The variant received 2 points.

O3Absent or very rare in population
Absent or extremely rare in gnomAD (AC ≤ 2) — O3 moderate; GnomAD: AF = 0.000001, AC = 1 — absent/extremely rare (O3 moderate [+2])

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_001042492.3. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

NF1 NM_001042492.3
MANE Select
HGVSc / HGVSpc.3496+53T>G
Exon rankIntron 26 of 57
intron
Prot: NP_001035957.1UniProt: P21359-1
NF1 NM_000267.4
HGVSc / HGVSpc.3496+53T>G
Exon rankIntron 26 of 56
intron
Prot: NP_000258.1UniProt: P21359-2

Ensembl Transcripts

NF1 ENST00000358273.9
TSL:1MANE Select
HGVSc / HGVSpc.3496+53T>G
Exon rankIntron 26 of 57
intron
Prot: ENSP00000351015.4UniProt: P21359-1
NF1 ENST00000356175.7
TSL:1
HGVSc / HGVSpc.3496+53T>G
Exon rankIntron 26 of 56
intron
Prot: ENSP00000348498.3UniProt: P21359-2
NF1 ENST00000579081.6
TSL:1
HGVSc / HGVSpn.3496+53T>G
Exon rankIntron 26 of 57
intron
Prot: ENSP00000462408.2UniProt: J3KSB5

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 3 sources
GnomAD3 genomes
Cov:32
GnomAD4 exome
AF: 6.84e-7
AC:1
Hom:0
AN:1461378
Cov:33
GnomAD4 genome
Cov:32
Showing 3 sources

ClinVar

Not reported in ClinVar

Computational Scores

AlphaGenome AVI
Benign6.0
BayesDel_noAF
Benign-0.82
CADD
Benign6.7
DANN
Benign0.64
GPN-Star LLR
N/A-0.18
GPN-Star score
N/A0.18
PhyloP100
Benign0.13
Showing 7 of 7 scores

Splicing Scores

Pangolin (max)
Benign0.070
SpliceAI score (max)
Benign0.010
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.